These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8408711)

  • 1. Rearrangements of c-myc and c-abl genes in tumour cells in Burkitt's lymphoma.
    Casares S; Rodríguez JM; Martin A; Parrado A
    J Clin Pathol; 1993 Aug; 46(8):778-9. PubMed ID: 8408711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular genetic features of sporadic Burkitt's lymphoma in children].
    Yang WP; Huang H; Gong LP; Wu Y; Xu HY; Zou Y; Lü BB; Zhong HS; Deng QQ; Xiao Q; Zeng ST; Zhu CD
    Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):819-24. PubMed ID: 21215097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Burkitt's lymphoma diagnosed by molecular analysis of DNA from malignant cells in ascites].
    Murata T; Harano H; Hashimoto Y; Matuzaki M; Mouri H; Kudoh J; Shimizu N; Okubo T
    Rinsho Ketsueki; 1992 Dec; 33(12):1834-8. PubMed ID: 1479695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A translocation t(8;14) and c-myc gene rearrangement associated with the histological transformation of B-cell acute lymphocytic leukemia (FAB-L2) into Burkitt's type (FAB-L3) leukemia.
    Masauzi N; Kasai M; Suzuki G; Kobayashi N; Ohizumi H; Ogasawara M; Kiyama Y; Naohara T; Saitoh M; Higa T; Tanaka J; Hashino S; Imamura M; Asaka M
    Leuk Lymphoma; 1997 Oct; 27(3-4):357-63. PubMed ID: 9402334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The intron enhancer of the immunoglobulin kappa gene activates c-myc but does not induce the Burkitt-specific promoter shift.
    Polack A; Strobl L; Feederle R; Schweizer M; Koch E; Eick D; Wiegand H; Bornkamm GW
    Oncogene; 1991 Nov; 6(11):2033-40. PubMed ID: 1945409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: relevance to geography and Epstein-Barr virus association.
    Shiramizu B; Barriga F; Neequaye J; Jafri A; Dalla-Favera R; Neri A; Guttierez M; Levine P; Magrath I
    Blood; 1991 Apr; 77(7):1516-26. PubMed ID: 1849033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rearrangement of the proto-oncogene c-myc in fresh cells from Burkitt's leukemia (L3)].
    Mathieu-Mahul D; Bernheim A; Berger R; Mauchauffe M; Flandrin G; Larsen CJ
    Nouv Rev Fr Hematol (1978); 1985; 27(3):157-61. PubMed ID: 2993997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An aggressive case of Burkitt's lymphoma with t(8;14) and c-myc rearrangement transformed from CD5+ B-cell lymphoma.
    Niwano H; Aoki S; Tsukada N; Toba K; Fuse I; Kishi K; Koike T; Takahashi H; Yamamori S; Shibata A; Aizawa Y
    Ann Hematol; 1997; 75(5-6):221-5. PubMed ID: 9433379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus and Burkitt's lymphoma.
    Magrath I; Jain V; Bhatia K
    Semin Cancer Biol; 1992 Oct; 3(5):285-95. PubMed ID: 1335792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary gastric Burkitt's lymphoma presenting with c-myc gene rearrangement.
    Andoh A; Takaya H; Bamba M; Sakumoto H; Inoue T; Tujikawa T; Koyama S; Fujiyama Y; Bamba T
    J Gastroenterol; 1998 Oct; 33(5):710-5. PubMed ID: 9773936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.
    Hummel M; Bentink S; Berger H; Klapper W; Wessendorf S; Barth TF; Bernd HW; Cogliatti SB; Dierlamm J; Feller AC; Hansmann ML; Haralambieva E; Harder L; Hasenclever D; Kühn M; Lenze D; Lichter P; Martin-Subero JI; Möller P; Müller-Hermelink HK; Ott G; Parwaresch RM; Pott C; Rosenwald A; Rosolowski M; Schwaenen C; Stürzenhofecker B; Szczepanowski M; Trautmann H; Wacker HH; Spang R; Loeffler M; Trümper L; Stein H; Siebert R;
    N Engl J Med; 2006 Jun; 354(23):2419-30. PubMed ID: 16760442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of genomic aberrations in molecularly defined Burkitt's lymphoma by array-based, high resolution, single nucleotide polymorphism analysis.
    Scholtysik R; Kreuz M; Klapper W; Burkhardt B; Feller AC; Hummel M; Loeffler M; Rosolowski M; Schwaenen C; Spang R; Stein H; Thorns C; Trümper L; Vater I; Wessendorf S; Zenz T; Siebert R; Küppers R;
    Haematologica; 2010 Dec; 95(12):2047-55. PubMed ID: 20823134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of somatic mutation within translocated c-myc genes in Burkitt's lymphoma.
    Rabbitts TH; Forster A; Hamlyn P; Baer R
    Nature; 1984 Jun 14-20; 309(5969):592-7. PubMed ID: 6547209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cationic lipids reduce time and dose of c-myc antisense oligodeoxynucleotides required to specifically inhibit Burkitt's lymphoma cell growth.
    Williams SA; Chang L; Buzby JS; Suen Y; Cairo MS
    Leukemia; 1996 Dec; 10(12):1980-9. PubMed ID: 8946941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional analysis of Burkitt's lymphoma mutant c-Myc proteins.
    Smith-Sørensen B; Hijmans EM; Beijersbergen RL; Bernards R
    J Biol Chem; 1996 Mar; 271(10):5513-8. PubMed ID: 8621409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular biology of Burkitt's lymphoma.
    Hecht JL; Aster JC
    J Clin Oncol; 2000 Nov; 18(21):3707-21. PubMed ID: 11054444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histogenetic correlations between subcategories of small noncleaved cell lymphomas.
    Yano T; van Krieken JH; Magrath IT; Longo DL; Jaffe ES; Raffeld M
    Blood; 1992 Mar; 79(5):1282-90. PubMed ID: 1311213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetic rearrangement of C-MYC oncogene occurs prior to infection with Epstein-Barr virus in the monoclonal malignant B cells from an AIDS patient.
    Roncella S; Di Celle PF; Cutrona G; Carbone A; Sessarego M; Landonio G; Foà R; Rowe M; Ferrarini M
    Leuk Lymphoma; 1993 Jan; 9(1-2):157-64. PubMed ID: 8386576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of the novel B acute lymphoblastic leukemia (FAB L3) cell line KHM-10B with a 13q34 abnormality and constitutive expression of c-myc and max during cell cycle.
    Sonoki T; Matsuzaki H; Miyamoto K; Taniwaki M; Yoshino T; Hata H; Yoshida M; Matsuno F; Nagasaki A; Kuribayashi N
    Leukemia; 1995 Dec; 9(12):2093-9. PubMed ID: 8609722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular analysis in Argentinian patients with Burkitt's lymphoma].
    Gutiérrez MI; Barriga F; Díez B; Larripa I; Magrath I
    Sangre (Barc); 1990 Feb; 35(1):10-4. PubMed ID: 2159189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.